lixisenatide
Selected indexed studies
- Trial of Lixisenatide in Early Parkinson's Disease. (N Engl J Med, 2024) [PMID:38598572]
- Lixisenatide. (, 2012) [PMID:31643608]
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. (N Engl J Med, 2015) [PMID:26630143]
_Worker-drafted node — pending editorial review._
Connections
lixisenatide is a side effect of
Sources
- Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. (2023) pubmed
- Trial of Lixisenatide in Early Parkinson's Disease. (2024) pubmed
- Lixisenatide. (2012) pubmed
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. (2015) pubmed
- Lixisenatide. (2017) pubmed
- Lixisenatide. (2006) pubmed
- Lixisenatide for the treatment of type 2 diabetes. (2013) pubmed
- GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. (2021) pubmed
- Lixisenatide: A New Daily GLP-1 Agonist for Type 2 Diabetes Management. (2017) pubmed
- Lixisenatide for type 2 diabetes. (2017) pubmed